Literature DB >> 4156084

Phenelzine in phobic states.

D Kelly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4156084      PMCID: PMC1645420     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  8 in total

Review 1.  Anxiety and drug therapy.

Authors:  D Kelly
Journal:  Proc R Soc Med       Date:  1973-03

2.  Phenelzine in phobic anxiety: a controlled trial.

Authors:  P Tyrer; J Candy; D Kelly
Journal:  Psychol Med       Date:  1973-02       Impact factor: 7.723

3.  A comparative study of aversion relief and systematic desensitization in the treatment of phobias.

Authors:  L Solyom; G R Heseltine; D J McClure; B Ledwidge; F Kenny
Journal:  Br J Psychiatry       Date:  1971-09       Impact factor: 9.319

4.  Acetylator status and response to phenelzine in depressed patients.

Authors:  E C Johnstone; W Marsh
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

5.  Treatment of phobic states with antidepressants. A retrospective study of 246 patients.

Authors:  D Kelly; W Guirguis; E Frommer; N Mitchell-Heggs; W Sargant
Journal:  Br J Psychiatry       Date:  1970-04       Impact factor: 9.319

6.  Behaviour therapy versus drug therapy in the treatment of phobic neurosis.

Authors:  L Solyom; G F Heseltine; D J McClure; C Solyom; B Ledwidge; G Steinberg
Journal:  Can Psychiatr Assoc J       Date:  1973-02

7.  Lactate metabolism in anxiety neurosis.

Authors:  F N Pitts; J N McClure
Journal:  N Engl J Med       Date:  1967-12-21       Impact factor: 91.245

8.  Anxiety and the effects of sodium lactate assessed clinically and physiologically.

Authors:  D Kelly; N Mitchell-Heggs; D Sherman
Journal:  Br J Psychiatry       Date:  1971-08       Impact factor: 9.319

  8 in total
  1 in total

1.  Are monoamine-oxidase inhibitors antidepressants?

Authors:  T P Tyrer
Journal:  Proc R Soc Med       Date:  1973-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.